Indaptus Therapeutics, Inc. (INDP)
2.355
-0.44
(-15.89%)
USD |
NASDAQ |
May 01, 16:00
2.41
+0.06
(+2.34%)
After-Hours: 17:30
Indaptus Therapeutics EPS Diluted (Quarterly) : -3.743 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.112M |
| Total Expenses (Quarterly) | 8.112M |
| Enterprise Value | -2.219M |
| Earnings Yield | -685.5% |
| Normalized Earnings Yield | -633.87 |